Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Hereditary Angioedema

In brief

HAE is a rare disorder characterized by functional C1 esterase inhibitor deficiency. If not treated adequately, the acute attacks of HAE can be life-threatening and may even result in fatalities, especially in case of swelling of the larynx. This clinical Phase 2/Phase 3 study was designed to provide clinically relevant data on dosing, efficacy and safety in subjects with HAE.

Key facts

Study ID

NCT00168103

Run by

CSL Behring

People needed

126

Starts

2005-06-01

Expected to finish

2007-12-01

Last updated by the study team

2015-03-31

Who can join

Age: 6 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study Site — Granada Hills, California, United States
• Study Site — Weston, Florida, United States
• Study Site — Atlanta, Georgia, United States
• Study Site — Idaho Falls, Idaho, United States
• Study Site — Chicago, Illinois, United States
• Study Site — Shreveport, Louisiana, United States
• Study Site — Boston, Massachusetts, United States
• Study Site — Plymouth, Minnesota, United States
• Study Site — Omaha, Nebraska, United States
• Study Site — The Bronx, New York, United States
• Study Site — Cincinnati, Ohio, United States
• Study Site — Tulsa, Oklahoma, United States
• Study Site — Eugene, Oregon, United States
• Study Site — Hershey, Pennsylvania, United States
• Study Site — Rapid City, South Dakota, United States
• Study Site — Dallas, Texas, United States
• Study Site — Bellingham, Washington, United States
• Study Site — Buenos Aires, Argentina
• Study Site — Westmead, Australia
• Study Site — Plovdiv, Bulgaria
• Study Site — Sofia, Bulgaria
• Study Site — Edmonton, Canada
• Study Site — Ottawa, Canada
• Study Site — Brno, Czechia
• Study Site — Budapest, Hungary

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.